Cyprus vs United Arab Emirates: The number of people with susceptibility test result for rifampicin
Cyprus
29
in 2021
United Arab Emirates
23
in 2021
Cyprus rank
128th
United Arab Emirates rank
131st
The number of people with susceptibility test result for rifampicin over time
- Cyprus
- United Arab Emirates
How they compare
Cyprus currently reports 29 against 23 in United Arab Emirates, a difference of 6.
That makes Cyprus's figure about 1.3 times United Arab Emirates's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was United Arab Emirates ahead.
Cyprus ranks 128th and United Arab Emirates ranks 131st of 155 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.67 | 32 | 5.67 | Cyprus |
| 2020s | 27 | 26 | 1 | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cyprus or United Arab Emirates?
- Cyprus, at 29 against 23 in United Arab Emirates as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cyprus and United Arab Emirates?
- 6, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and United Arab Emirates?
- 5 years are reported by both, from 2017 to 2021.
- How do Cyprus and United Arab Emirates rank globally for the number of people with susceptibility test result for rifampicin?
- Cyprus ranks 128th and United Arab Emirates ranks 131st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.